Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Direct-to-Consumer Drug Commercials Often Misleading: Study September 26, 2013 Irvin Jackson Add Your Comments According to the findings of new research, most of the commercials seen on television for medications are misleading, with about one out of every 10 containing false statements.  In a study published this month in the Journal of General Internal Medicine, researchers from the Dartmouth Institute for Health Policy found that six out of every 10 direct-to-consumer drug advertisements shown on television provide false or misleading information, including both prescription and over-the-counter drugs commercials aimed consumers. Researchers looked at drug ads from 2008 through 2010, which aired during the nightly news on major networks. Only 33% of the commercials consisted entirely of statements that were objectively true. However, 57% contained claims that were potentially misleading and 10% made outright false statements, according to the report. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Commercials for prescription drugs tended to be slightly more accurate and made fewer false statements than those for over-the-counter drugs, the researchers found. When over-the-counter ads were looked at separately, the number of misleading or false claims jumped to 80%. “Healthcare consumers need unrestricted access to high-quality information about health, but these TV drug ads had misleading statements that omitted or exaggerated information,” lead researcher Adrienne E. Faerber, of The Dartmouth Institute for Health Policy & Clinical Practice, said in a press release. “These results conflict with arguments that drug ads are helping inform consumers.” The researchers point out that some of the differences in prescription and non-prescription drug advertising may be due to regulations. Prescription drug advertising is overseen by the FDA, but over -the-counter drug ads are regulated by the Federal Trade Commission (FTC). The agencies have different definitions for what constitutes a false or misleading claim. While a number of different pharmaceutical companies were found to provide misleading advertisements, Bayer Healthcare has repeatedly got itself into hot water in recent years over television commercials for prescription drugs. Bayer has been warned at least three times by the FDA, in 2003, 2008 and 2009, over problems with Yasmin or Yaz birth control pill advertisements. The drug maker has been cited for misleading the public through the use of ads that overstated the efficacy and benefits of Yaz and Yasmin, while minimizing serious risks associated with the drug. In 2009, Bayer was forced to run a $20 million corrective advertising campaign to address problems with Yaz advertisements that stressed the potential benefits in treating acne and symptoms of PMS, while minimizing the potential risk of blood clots. The ads were found to be in violation of a 2007 agreement Bayer made with the FDA after earlier deceptive advertising campaigns. For the next several years, Bayer was required to submit any future Yaz advertisements in the United States to the FDA for approval before they are aired. Bayer now faces thousands of Yaz lawsuits and Yasmin lawsuits by women, or the families of women who died while taking the pills. All of the complaints claim that the company failed to adequately warn doctors and patients of the health risks of the Yaz and Yasmin oral contraceptives. The drug maker has paid out at least $1.4 billion to settle claims of injury due to blood clots and gallbladder injuries and, despite the massive Yaz and Yasmin settlements, still faces several thousand product liability lawsuits that have not yet been settled. Many critics of direct-to-consumer advertisements for prescription medications argue that the commercials inappropriately encourage individuals to contact their doctors and ask for certain brand name drugs, leading to increases in prescription therapy when alternative treatments or life-style changes may be a more appropriate first line course. A recent study published in the Journal of General Internal Medicine highlighted how advertisements for statin-based cholesterol drugs increase use of the medications among individuals with relatively low risk of heart disease, which the blockbuster drugs are designed to prevent, yet individuals at a higher risk for heart disease often ignore the advertisements. Amid aggressive advertising, statin medications like Lipitor, Zocor and Crestor have become the most widely used medications in the United States, generating more than $15 billion in combined annual sales. The findings came amid rising concerns about the safety and effectiveness of the medications, including a growing number of Lipitor lawsuits that allege Pfizer has withheld important information from consumers about the impact of the medication on blood glucose levels. Tags: Bayer, Birth Control Pill, Drug Side Effects, Yasmin, Yaz More Lawsuit Stories More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies April 17, 2025 AngioDynamics SmartPort Infection Resulted in Removal of Failed Port Catheter: Lawsuit April 17, 2025 Allstate Driving Data Collection Lawsuits Consolidated in Northern District of Illinois April 17, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (Posted: today) Nearly a dozen different cosmetics companies face more than 12,000 hair relaxer lawsuits, involving claims that chemical straighteners caused women to develop uterine cancer, endometrial cancer, ovarian cancer and other injuries. MORE ABOUT: HAIR RELAXER LAWSUITUterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025) Paraquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (Posted: yesterday) Lawyers involved in Paraquat Parkinson’s disease lawsuits pending in the federal court system indicate that they have reached an agreement to settle many of the claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSAppeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)Farmers Exposed to Certain Pesticides Face an Increased Risk of Rheumatoid Arthritis (12/11/2024) Status of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (Posted: yesterday) A federal judge will meet with lawyers involved with Suboxone tooth loss lawsuits tomorrow, to review the status of pretrial proceedings in claims brought by individuals throughout the U.S. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITPrenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025)Suboxone Lawsuit Filing Deadline Nears for Many Tooth Decay Claims in 3-Year SOL States (04/07/2025)Up to 100 Suboxone Tooth Decay Claims Can Be Filed on Single Lawsuit in MDL: Judge (03/17/2025)
More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies April 17, 2025
AngioDynamics SmartPort Infection Resulted in Removal of Failed Port Catheter: Lawsuit April 17, 2025
Allstate Driving Data Collection Lawsuits Consolidated in Northern District of Illinois April 17, 2025
More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (Posted: today) Nearly a dozen different cosmetics companies face more than 12,000 hair relaxer lawsuits, involving claims that chemical straighteners caused women to develop uterine cancer, endometrial cancer, ovarian cancer and other injuries. MORE ABOUT: HAIR RELAXER LAWSUITUterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)
Paraquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (Posted: yesterday) Lawyers involved in Paraquat Parkinson’s disease lawsuits pending in the federal court system indicate that they have reached an agreement to settle many of the claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSAppeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)Farmers Exposed to Certain Pesticides Face an Increased Risk of Rheumatoid Arthritis (12/11/2024)
Status of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (Posted: yesterday) A federal judge will meet with lawyers involved with Suboxone tooth loss lawsuits tomorrow, to review the status of pretrial proceedings in claims brought by individuals throughout the U.S. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITPrenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025)Suboxone Lawsuit Filing Deadline Nears for Many Tooth Decay Claims in 3-Year SOL States (04/07/2025)Up to 100 Suboxone Tooth Decay Claims Can Be Filed on Single Lawsuit in MDL: Judge (03/17/2025)